|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
| MMS FOB |
Admitted
|
2020 | 710 GMAT Classic | 2 | Healthcare/Pharmaceuticals | India |
24 Mar 2020 05:14 AM
|
||
| Full Time MBA |
Waitlisted with Interview
|
R2 | 2020 | 720 GMAT Classic | 3 | United States |
23 Mar 2020 09:33 PM
|
||
| Full Time MBA |
Waitlisted with Interview
|
R2 | 2020 | 334 GRE | 3.9 | 5 | Consulting | United States |
22 Mar 2020 01:27 PM
|
| Full Time MBA |
Waitlisted with Interview
|
R2 | 2020 | 760 GMAT Classic | 3.8 | 8 | Pharmaceuticals and Biotech | United States |
22 Mar 2020 01:35 AM
|
| Full Time MBA |
Admitted
|
R2 | 2020 | 328 GRE | 3.7 | 5 | United States |
21 Mar 2020 11:22 PM
|
|
| Full Time MBA |
Waitlisted with Interview
|
R2 | 2020 | 740 GMAT Classic | 6 | Consulting | Viet Nam |
20 Mar 2020 11:24 PM
|
|
| Full Time MBA |
Waitlisted with Interview
|
R2 | 2020 | 700 GMAT Classic | United States |
20 Mar 2020 04:02 PM
|
|||
| Full Time MBA |
Admitted
|
R2 | 2020 | 326 GRE | 3.5 | 7 | Non-Profit and Government | United States |
20 Mar 2020 03:31 PM
|
|
Admitted
|
R4 | 2020 | 690 GMAT Classic | United States |
20 Mar 2020 11:55 AM
|
||||
| Full Time MBA |
Admitted
|
R2 | 2020 | 730 GMAT Classic | 3.2 | 4 | United States |
20 Mar 2020 08:52 AM
|
|
| Full Time MBA |
Waitlisted with Interview
|
R2 | 2020 | 760 GMAT Classic | 4 | Healthcare/Pharmaceuticals | China |
20 Mar 2020 08:50 AM
|
|
| Full Time MBA |
Denied without Interview
|
R2 | 2020 | 740 GMAT Classic | 3.7 | 7 | Consulting | India |
20 Mar 2020 08:02 AM
|
| Full Time MBA |
Admitted
|
R2 | 2020 | 700 GMAT Classic | 3.6 | 3 | Healthcare/Pharmaceuticals | Chile |
20 Mar 2020 07:01 AM
|
| Full Time MBA |
Waitlisted without Interview
|
R2 | 2020 | 700 GMAT Classic | 5 | Other | Korea, Republic of |
19 Mar 2020 10:15 PM
|
|
| Full Time MBA |
Denied with Interview
|
R2 | 2020 | 740 GMAT Classic | 3.4 | 7 | Finance: Venture Capital | Hong Kong |
19 Mar 2020 07:50 PM
|
| Full Time MBA |
Admitted
|
R2 | 2020 | 3 | 4 | Computer Software | United States |
19 Mar 2020 06:58 PM
|
|
| Full Time MBA |
Admitted
|
R2 | 2020 | 720 GMAT Classic | 3.5 | 6 | Other | United States |
19 Mar 2020 06:35 PM
|
| Full Time MBA |
Waitlisted with Interview
|
R2 | 2020 | 700 GMAT Classic | 5 | Peru |
19 Mar 2020 04:32 PM
|
||
| Full Time MBA |
Waitlisted without Interview
|
R2 | 2020 | 710 GMAT Classic | 6 | Healthcare/Pharmaceuticals | United States |
19 Mar 2020 04:18 PM
|
|
| Full Time MBA |
Waitlisted with Interview
|
R2 | 2020 | 730 GMAT Classic | 4 | 3 | United States |
19 Mar 2020 04:10 PM
|